Datadog Inc vs 10X Genomics Inc — how do they compare? Datadog Inc trades at $243.15 (market cap $88.61B), while 10X Genomics Inc trades at $59.34 (market cap $7.61B). The key difference: Datadog Inc is far larger — about 11.6× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Datadog Inc nearer its low. Which is the better fit depends on your goals.
| DDOG | TXG | |
|---|---|---|
Market Cap | $88.61B | $7.61B |
Sector | Technology | Health |
52-Week High | $288.15 | $58.57 |
52-Week Low | $102.62 | $11.34 |
Enterprise Value | $84.90B | $7.14B |
Signals from Pluang's Aura AI — not financial advice
Datadog (DDOG) trades at $260.78, up 11.48% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat expectations with EPS of $0.65 versus $0.583 estimated. Revenue grew 36% year-over-year, and the company raised full-year 2026 guidance. Technical indicators show a bullish trend with support at $239 and resistance at $272, while high valuation multiples like a P/E of 493.56 signal premium pricing. Recent news highlights AI-driven growth but also insider selling and market sensitivity to guidance nuances.
The outlook remains positive due to robust revenue growth and AI adoption, but risks include elevated valuations and customer concentration. Analyst consensus is strongly bullish with an average price target of $288.55, though investors should monitor execution against high expectations and competitive pressures in the cloud monitoring space.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered as software-as-a-service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of different applications throughout their businesses.
Read more on DDOG →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →